Rapid advances in genomic technologies and their increasing clinical application are driving the need for a policy on whether to recontact patients to inform them of new genetic discoveries that may have relevance to their health. Importantly, the duty to recontact is context-specific, and professionals should be offered guidance accordingly.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Experiences of pediatric cancer patients (age 12–18 years) with extensive germline sequencing for cancer predisposition: a qualitative study
European Journal of Human Genetics Open Access 27 February 2024
-
Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications
Genome Medicine Open Access 17 June 2022
-
Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting
European Journal of Human Genetics Open Access 11 March 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pyeritz, R. E. The coming explosion in genetic testing — is there a duty to recontact? N. Engl. J. Med. 365, 1367–1369 (2011).
Otten, E. et al. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet. Med. 17, 668–678 (2015).
David, K. L. et al. Patient re-contact after revision of genomic test results: points to consider — a statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. https://doi.org/10.1038/s41436-018-0391-z (2018).
Carrieri, D. et al. Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 27, 169–182 (2019).
Wouters, R. H. P. et al. Am I my family’s keeper? Disclosure dilemmas in next-generation sequencing. Hum. Mutat. 37, 1257–1262 (2016).
Bredenoord, A. L. et al. Disclosure of individual genetic data to research participants: the debate reconsidered. Trends Genet. 27, 41–47 (2011).
Wade, C. H. & Kalfoglou, A. L. When do genetic researchers have a duty to recontact study participants? Am. J. Bioeth. 6, 26–27 (2006).
Ploem, C. et al. A duty to recontact in the context of genetics: futuristic or realistic? Eur. J. Health Law 25, 537–553 (2018).
Acknowledgements
This paper is written as part of the technology assessment of next-generation sequencing in personalized oncology (TANGO) project, funded by ZonMw, The Hague, Netherlands.
Author information
Authors and Affiliations
Contributions
N.A.A.G. researched the literature. All authors contributed to discussions of the content, wrote the article and reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Giesbertz, N.A.A., van Harten, W.H. & Bredenoord, A.L. A duty to recontact in genetics: context matters. Nat Rev Genet 20, 371–372 (2019). https://doi.org/10.1038/s41576-019-0121-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41576-019-0121-7
This article is cited by
-
Experiences of pediatric cancer patients (age 12–18 years) with extensive germline sequencing for cancer predisposition: a qualitative study
European Journal of Human Genetics (2024)
-
Equity implications of patient-initiated recontact and follow-up in clinical genetics
European Journal of Human Genetics (2023)
-
Recontact: a survey of current practices and BRCA1/2 testing in Japan
Journal of Human Genetics (2023)
-
The Need to Standardize the Reanalysis of Genomic Sequencing Results: Findings from Interviews with Underserved Families in Genomic Research
Journal of Bioethical Inquiry (2023)
-
Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting
European Journal of Human Genetics (2022)